References
Bickler SW (2000) Non-communicable diseases: is their emergence in industrialized societies related to changes in neuroendocrine function? Med Hypotheses 54:825–858
Bickler SW (2006) Tropical enteropathy protects against Western diseases in environments of poor sanitation. Med Hypotheses 67:146–150
Bickler SW, De Maio A (2008) Western diseases: current concepts and implications for pediatric surgery research and practice. Pediatr Surg Int 24:251–255
Bowen ETW, Lloyd G, Harris WJ, Platt GS, Baskerville A, Vella EE (1977) Viral haemorrhagic fever in Southern Sudan and Northern Zaire. Lancet 1:571–573
Carette JE, Raaben M, Wong AC et al (2011) Ebola virus entry requires the cholesterol transporter Niemann-Pick C1. Nature 477:340–343
Chan M (2014) “WHO Director-General addresses UN security council on Ebola.” World Health Organization, September 18, 2014. http://www.who.int/dg/speeches/2014/security-council-ebola/en/. Accessed 28 Oct 2014
Chowell G, Nishiura H (2014) Transmission dynamics and control of Ebola virus disease (EVD): a review. BMC Med 12:196
Coté M, Misasi J, Ren T et al (2011) Small molecule inhibitors reveal Niemann-Pick C1 is essential for Ebola virus infection. Nature 477:344–348
Fedson DS (2014) How will physicians respond to the next influenza pandemic? Clin Infect Dis 58:233–237
Frey T, De Maio A (2007) Increased expression of CD14 in macrophages after inhibition of the cholesterol biosynthetic pathway by lovastatin. Mol Med 13:592–604
Frey T, De Maio A (2009) The antifungal agent itraconazole induces the accumulation of high mannos glycoproteins in macrophages. J Biol Chem 284:16882–16890
Idaghdour Y, Storey JD, Jadallah SJ, Gibson G (2008) A genome-wide gene expression signature of environmental geography in leukocytes of Moroccan Amazighs. PLoS Genet 4:e1000052
Johnson KM, Webb PA, Lange JV, Murphy FA (1977) A new virus causing acute haemorrhagic fever in Zaire. Lancet 1:569–571
Kohjima M, Enjoji M, Yoshimoto T et al (2013) Add-on therapy of pitavastatin and eicosapentaenoic acid improves outcome of peginterferon plus ribavirin treatment for chronic hepatitis C. J Med Virol 85:250–260
Krishnan A, Miller EH, Herbert AS et al (2012) Niemann-Pick C1 (NPC1)/NPC1-like1 chimeras define sequences critical for NPC1’s function as a filovirus entry receptor. Viruses 4:2471–2484
Mañes S, del Real G, Martinez AC (2003) Pathogens: raft hijackers. Nat Rev 3:557–568
Martines RB, Ng DL, Greer PW, Rollin PE, Zaki SR (2014) Tissue and cellular tropism, pathology and pathogenesis of Ebola and Marburg viruses. J Pathol. doi:10.1002/path.4456
Miller EH, Chandran K (2012) Filovirus entry into cells—new insights. Curr Opin Virol 2:206–214
Nath AP, Arafat D, Gibson G (2012) Using blood informative transcripts in geographical genomics: impact of lifestyle on gene expression in Fijians. Front Genet 3:243
Ng M, Ndungo E, Jangra RK et al (2014) Cell entry by a novel European filovirus requires host endosomal cysteine proteases and Niemann-Pick C1. Virology 468-470C:637–646
Niño DF, Cauvi DM, De Maio A (2014) Itraconazole, a commonly used antifungal, inhibits Fcγ receptor-mediated phagocystosis: alteration of Fcγ receptor glycosylation and gene expression. Shock 42:52–59
Rosenbaum AI, Maxfield FR (2011) Niemann-Pick type C disease: molecular mechanisms and potential therapeutic approaches. J Neurochem 116:789–795
Shoemaker CJ, Chornberg KL, Delos SE et al (2013) Multiple cationic amphiphiles induce a Niemann-Pick C phenotype and inhibit Ebola virus entry and infection. PLoS One 8:e56265
Vasunilashorn S, Crimmins EM, Kim JKI et al (2010) Blood lipids, infection, and inflammatory markers in the Tsimane of Bolivia. Am J Hum Biol 22:731–740
WHO (2014a) October 25 Ebola Response Roadmap. World Health Organization. http://apps.who.int/iris/bitstream/10665/137185/1/roadmapupdate25Oct14_eng.pdf?ua=1. Accessed October 28, 2014
WHO (2014b) Ebola Response Roadmap. World Health Organization. http://apps.who.int/iris/bitstream/10665/131596/1/EbolaResponseRoadmap.pdf?ua=1&ua=1. Accessed October 28, 2014
WHO Ebola Response Team (2014) Ebola virus disease in West Africa—first 9 months of the epidemic and forward projections. N Engl J Med 371:1481–1495
Acknowledgments
This work was supported by the National Institutes of General Medical Sciences (GM R01 098455) and Fogarty International Center (R24TW008910).
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Bickler, S.W., Lizardo, R.E. & De Maio, A. The transition from a rural to an urban environment alters expression of the human Ebola virus receptor Neiman-Pick C1: implications for the current epidemic in West Africa. Cell Stress and Chaperones 20, 203–206 (2015). https://doi.org/10.1007/s12192-014-0557-9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12192-014-0557-9